I-Mab Biopharma
IMAB
#9469
Rank
S$74.56 M
Marketcap
$0.91
Share price
-6.87%
Change (1 day)
-62.95%
Change (1 year)

I-Mab Biopharma (IMAB) - Cash on Hand

Cash on Hand as of September 2024 : S$0.24 Billion

According to I-Mab Biopharma's latest financial reports the company has S$0.24 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

I-Mab Biopharma - Cash on Hand chart (from 2024 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$60.21 M-38.04%
2022-12-31S$97.18 M-31.73%
2021-12-31S$0.14 B-4.28%
2020-12-31S$0.14 B361.05%
2019-12-31S$32.25 M-39.43%
2018-12-31S$53.25 M194.55%
2017-12-31S$18.08 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$22.05 M-91.11%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.58 B 134.25%๐Ÿ‡บ๐Ÿ‡ธ USA